CRISPR Therapeutics becomes commercial-stage company after FDA approves CASGEVY
AI Summary- CRISPR Therapeutics advanced to commercial-stage status after CASGEVY received FDA approval.
- CASGEVY is the company’s FDA-approved gene-editing therapy.
- The approval validates CRISPR/Cas9 and supports CRISPR Therapeutics’ pipeline targeting large markets.